Peptides discussed here are not FDA-approved for human therapeutic use
Phase 2: Tirzepatide Titration + Ipamorelin Introduction (Weeks 4 through 8) At week four, your physician will assess your tolerance and may increase tirzepatide to 5 mg weekly

Resources and Next Steps Professional Organizations Academy of Nutrition and Dietetics Pediatric Nutrition Practice Group The Obesity Society Pediatric Obesity Section American Academy of Pediatrics Obesity guidelines and resources Pediatric Endocrine Society GLP-1 position statements Key Research and Guidelines AAP Clinical Practice Guideline for Obesity (2023) Pediatrics: GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity (2025) NEJM: Semaglutide in Adolescents with Obesity (2022) CMAJ: Canadian Pediatric Obesity Guidelines Continuing Education Opportunities CDR Certificate of Training in Obesity for Pediatrics and Adults Board Certification in Pediatric Nutrition (CSP) Board Certification in Obesity and Weight Management (CSOWM) University-based certificate programs in pediatric weight management Stay Current Set up PubMed alerts for GLP-1 AND pediatric Follow pediatric endocrinologists on social media Join the Pediatric Nutrition Practice Group listserv Attend ObesityWeek for the latest research Your Next Steps Assess Your Current Knowledge: Take stock of what you know about GLP-1 medications and identify any knowledge gaps.s Choose Initial Training: Begin with free resources, such as podcasts and webinars

B12 is not considered toxic if you get too much, Scott said: "The body has the ability to excrete excess." The recommended daily allowance for a regular (non-pregnant, non-lactating) adult is 2.4 micrograms per day
All these applications require a powerful energy burst in a short period of time
But lately headlines are broadcasting a new finding that people who quit GLP-1s regain the weight even faster than people who used other methods to lose weight, like diet and exercise